Physician

Laxmaiah Manchikanti, M.D.

According to 2025 Medicare claims, Laxmaiah Manchikanti, M.D. (NPI: 1730178799) practices interventional pain management (ipm) in the Paducah, KY-IL market, with the plurality of this provider's patient population coming from Mc Cracken, KY. This provider's primary affiliated billing organization is PAIN MANAGEMENT CENTERS OF AMERICA, PSC (NPI: 1992271811; TIN: 832058987) and primary practice location at 42001-5619. Manchikanti is affiliated with the IRCCO (ACO ID: A2619), Caravan Health ACO 50 LLC (ACO ID: A5160), and The Rural Advantage LLC (ACO ID: A5257), participating under the MSSP model.

Manchikanti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 710 traditional Medicare patients, billed 3,913 HCPCS/CPT codes, and received $305,112 in Medicare payments. The top billing code was G0480 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 16,034 prescription claims across 1,811 beneficiaries totaling $442,061 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). Open Payments data shows 2 records totaling $114. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $549,948 and ending at $305,112. Concurrently, Part D prescription costs have declined steadily, from $763,512 to $442,061. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,515	9,992	$549,948
2016	1,251	8,587	$460,915
2017	1,120	10,665	$646,436
2018	1,036	9,023	$573,761
2019	1,097	9,143	$640,443
2020	1,070	6,906	$483,636
2021	994	6,955	$609,204
2022	845	5,271	$419,397
2023	808	4,810	$370,226
2024	710	3,913	$305,112

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,846	20,413	$763,512
2016	1,537	17,392	$627,087
2017	1,367	14,259	$496,605
2018	1,361	13,556	$532,417
2019	1,217	12,350	$489,048
2020	1,231	12,502	$357,301
2021	1,432	11,583	$369,603
2022	1,526	14,725	$494,241
2023	1,817	14,495	$535,375
2024	1,811	16,034	$442,061

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	320	406	$111
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	125	304	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	537	991	$78
80307	Testing for presence of drug, by chemistry analyzers	469	704	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	158	223	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	3,657	109,037	$93,615
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	4,216	125,577	$88,340
Movantik	Naloxegol Oxalate	119	3,622	$47,620
Gabapentin	Gabapentin	2,586	77,799	$22,507
Oxycontin	Oxycodone Hcl	27	810	$19,793

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$114	Curonix LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laxmaiah Manchikanti, M.D.?

Tedicare shows public-source Medicare data for Laxmaiah Manchikanti, M.D. (NPI 1730178799), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laxmaiah Manchikanti, M.D. have ACO affiliation data?

Laxmaiah Manchikanti, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and The Rural Advantage LLC (MSSP, ACO ID A5257).

What billing organization is linked to Laxmaiah Manchikanti, M.D.?

Laxmaiah Manchikanti, M.D. is linked to PAIN MANAGEMENT CENTERS OF AMERICA, PSC (billing NPI 1992271811) in the available physician profile data.

Does Laxmaiah Manchikanti, M.D. have Open Payments data?

Laxmaiah Manchikanti, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.